Mendelian randomization supports genetic liability to hospitalization for COVID-19 as a risk factor of pre-eclampsia

Mendelian randomization supports genetic liability to hospitalization for COVID-19 as a risk factor of pre-eclampsia

BackgroundPre-eclampsia and eclampsia are among the major threats to pregnant women and fetuses, but they can be mitigated by prevention and early screening. Existing observational research presents conflicting evidence regarding the causal effects of coronavirus disease 2019 (COVID-19) on pre-eclam...

Full description

Bibliographic Details
Main Authors: Weizhen Wu, Junning Zhang, Yizhuo Qiao, Yuehan Ren, Xuezhi Rao, Zhijie Xu, Baoxing Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Mendelian randomization
COVID-19
pre-eclampsia
eclampsia
EBI
GWAS
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1327497/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2024.1327497/full

Similar Items